Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration‐resistant prostate cancer who progress after docetaxel and abiraterone treatment
暂无分享,去创建一个
A. Bergman | H. van Tinteren | M. Los | V. van der Noort | P. Hamberg | I. V. van Oort | H. P. van den Berg | A. van den Eertwegh | I. D. de Jong | E. Kerver | J. Coenen | S. Badrising | E. D. Kerver